Novoeight and Stelara (Ustekinumab Intravenous Infusion)
Determining the interaction of Novoeight and Stelara (Ustekinumab Intravenous Infusion) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Stelara
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Novoeight-Stelara (Ustekinumab Subcutaneous Injection)
- Novoeight-Stelazine
- Novoeight-Stemetic
- Novoeight-Stemetil
- Novoeight-Stendra
- Novoeight-Sterapred
- Stelara (Ustekinumab Intravenous Infusion)-Novoeight recombinant
- Stelara (Ustekinumab Intravenous Infusion)-Novolin 70/30
- Stelara (Ustekinumab Intravenous Infusion)-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Stelara (Ustekinumab Intravenous Infusion)-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Stelara (Ustekinumab Intravenous Infusion)-Novolin N
- Stelara (Ustekinumab Intravenous Infusion)-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))